Chengdu Kanghong Pharmaceutical Group's low P/E ratio may si...

Chengdu Kanghong Pharmaceutical Group's low P/E ratio may signal bullishness, but shareholders may be uneasy as the company potentially faces a less prosperous future. The company's poor earnings outlook contributes to its low P/E, making a strong share price rise unlikely soon.